Postoperative instillation of mitomycin eye drops in the treatment of primary pterygium.
1. Pterygia, triangular sheets of fibrovascular tissue that invade the cornea, have recurrence rates of 30% to 50% with currently available surgical procedures. 2. Mitomycin, an antimetabolite-antibiotic agent, has been reported to be effective in preventing recurrences of surgically excised pterygia when used adjunctively as eye drops. 3. Because mitomycin-C is an antineoplastic agent, appropriate policies and proper patient education are important.
Spires
R
R
D006801:Humans; D008937:Mitomycins / Q000008:administration & dosage / Q000627:therapeutic use*; D010347:Patient Care Planning; D010353:Patient Education as Topic; D011182:Postoperative Care; D011625:Pterygium / Q000188:drug therapy* / Q000451:nursing / Q000601:surgery; D012008:Recurrence
D008937:Mitomycins